Morgantown, WV, United States of America

Daniel A Snider


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel A. Snider from Morgantown, WV

Introduction

Daniel A. Snider, an accomplished inventor based in Morgantown, West Virginia, has made significant contributions to the field of pharmaceuticals. With a focus on enhancing drug formulations, Snider's work addresses critical needs in medication efficiency and patient care.

Latest Patents

Snider holds two innovative patents that showcase his expertise in pharmaceutical compositions. His latest patent, titled "Phenytoin Sodium Pharmaceutical Compositions," presents a novel formulation that includes an admixture of phenytoin sodium and an erodible matrix. This composition is designed to extend the release of phenytoin sodium for about a two-hour period. The erodible matrix consists of various binder(s) and diluent(s) that precisely control the release of the drug. Furthermore, it may also include an alkaline pH modifier to enhance its effectiveness.

Career Highlights

Daniel A. Snider is currently affiliated with Mylan Pharmaceuticals Inc., where he utilizes his knowledge and skills to develop innovative pharmaceutical solutions. His work has a direct impact on the improvement of medication delivery systems, ensuring better therapeutic outcomes for patients.

Collaborations

Throughout his career, Snider has collaborated with notable professionals, including his coworkers William J. Addicks and Joseph P. Duda. These collaborations have played a critical role in driving forward his research and development efforts within the pharmaceutical industry.

Conclusion

Daniel A. Snider's contributions to pharmaceutical innovations underscore the importance of advancing drug delivery systems. With his patents, he continues to play an essential role in improving patient care and medication efficacy, making him a noteworthy inventor in the field. As he continues his work at Mylan Pharmaceuticals Inc., the impact of his innovations is poised to resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…